Post-menopausal women are more prone to breast cancer than younger women. The increased frequency of age-related breast cancers is likely due to interactions between acquired mutations and age-dependent epigenetic changes that affect mammary epithelial lineage fidelity. We hypothesized that the aging process fundamentally affects how human mammary epithelial cells (HMEC) respond to microenvironmental signals, resulting in increased susceptibility to oncogenic transformation. In order to measure microenvironmental cell signaling in normal finite lifespan HMEC, we applied a novel microsphere-based flow cytometry technology. The microsphere cytometry allows multiparametric single cell quantification of signaling pathway activity and lineage-specific marker expression in cells adhered to surfacefunctionalized microspheres that mimic specific microenvironments. Using this approach, we analyzed age-dependent changes in human mammary myoepithelial and luminal epithelial cells exposed to different ECM and growth factors. We found that ECM-mediated MAP kinase and PI3 kinase activation levels in HMEC were attenuated with age. Older luminal cells displayed higher surface integrin levels consistent with acquired basal identity, albeit with decreased integrin activation and increased Src-signaling relative to myoepithelial cells. We show that the diminished signaling magnitude in HMEC from older women correlated with reduced probability of activating oncogeneinduced senescence. We propose that age-related changes in ECM-mediated epithelial cell regulation may impair protective tumor suppression mechanisms and increase breast cancer susceptibility.
Introduction
Age is indisputably the highest risk factor for developing cancer. A recent study reported that over half of current adults under the age of 65 years will be diagnosed with cancer at some point in their lifetime, due to increased overall lifespan 1 . More than 75% of breast cancers occur among woman over the age of 50 2 . Accumulation of gene mutations is the predominant model to explain these observations. However, age related breast cancer is not associated with specific mutations and the trend attenuates after the age of 70 3 . The mechanisms of aging comprise common intrinsic factors; such as telomere shortening and senescence, and tissue-level factors; such as replacement of epithelial cells with adipocytes and accumulating loci of fibrotic rigidity due to glucose oxidation and subsequent crosslinking of collagen I [4] [5] [6] [7] . The conflation of intrinsic and microenvironmental factors results in significant age-related transcriptional changes 8, 9 . Aging is associated with emergent mammary epithelial cell phenotypes in particular in the luminal compartment. Subsets of luminal cells acquire basal traits that are related to phenotypic changes associated with BRCA1 mutations 10, 11 . We reasoned that age-emergent HMEC phenotypes will respond differently to microenvironmental cues and affect tumor suppressive senescence barriers. To address this possibility, we investigated normal, pre-stasis, finite lifespan human mammary epithelial cells (HMEC) from reduction mammoplasty, deriving from two groups of women; aged <30(y)ears and >58y. We applied a novel microsphere cytometry method to measure HMEC signaling at the single cell level within heterogeneous cell populations in the context of different extracellular matrix proteins (ECM) and growth factors.
We found altered ECM-mediated MAPK and PI3K-AKT pathway signaling with age, and evidence that decreased signaling in aged HMEC reduces the probability of activating tumor suppressive senescence barriers 12 .
Results

ECM-mediated signaling was altered in older human mammary epithelial cells
In order to measure ECM-mediated cell signaling responses in adherent HMEC, we applied a novel microsphere cytometry technique 13 . Microspheres were coated with E cadherin to mimic cell-cell contact 14 and extracellular matrix proteins (ECM) (collagen 1 (COL1), fibronectin (FN) or laminin (LAM)) to mimic the extracellular matrix ( Fig. 1A) , and mixed with low passage (4p) pre-stasis HMEC strains 15 derived from reduction mammoplasty or mastectomy tissues from women between the age of 19-91y. HMEC were allowed to adhere to coated microspheres for 2.5 hours prior to treatment and analysis by flow cytometry. DNA staining and side scatter analysis allowed unambiguous identification of single cells bound to individual microspheres ( Fig.1B) . Human mammary luminal (LEP) and myoepithelial (MEP) cells were distinguished by expression of cell surface markers (MEP:CD10 + CD227 -; LEP:CD227 + CD10 -).
Staining with anti-pERK and anti-pAKT was used to measure MAPK and PI3-AKT pathway activation respectively. Basal phosphorylation levels in cells were established by pretreatment with pERK and pAKT inhibitors (PD98059, wortmannin). Cells with phosphoprotein-levels above the basal phosphorylation levels were defined as responding (Fig.1C ). The geometric mean fluorescence intensity (GMFI) value of anti-pERK and anti-pAKT levels in the responding population was used to determine the strength of cell response at different ages ( Fig.1C ). Linear regression analysis of GMFI of the responding populations as a function of age revealed a reduction in the responses of LEP and MEP to different ECM proteins with age ( Fig.1D ; Suppl. Fig.1 ). pERK activation levels were significantly correlated with age in both LEP and MEP when adhered to FN. A similar trend was observed for COL1 and LAM, suggesting that ECMmediated cell signaling was diminished with age. Notably, the relative percentage of HMEC within the response gate did not change, showing that the attenuated phosphoprotein levels were due to decreased signaling magnitude and not fewer responding cells (Suppl. Fig.2C )
In order to determine growth factor-mediated AKT and ERK activation in different ECM contexts, we stimulated microsphere-bound HMEC for 20 minutes with complete M87 medium, comprising several growth factors (see experimental methods), and measured the relative change in pAKT and pERK levels for HMEC (Suppl. Fig.2A ). AKT and ERK activation in response to the growth factors did not show significant changes with age (Suppl. Fig. 2B ). We propose that HMEC exhibit age-dependent responses to different ECM, but that growth factor-mediated activation is age independent.
Cell responsiveness to ECM is altered with increasing age
In order to further investigate the nature of the ECM response with age, longitudinal cell signaling responses were analyzed in HMEC adhered to ECMcoated microspheres while incubated in M87 complete medium. pERK levels were monitored in HMEC between 0-2 hours following adhesion to ECM-coated microspheres. HMEC displayed a sigmoidal pERK response with the major inflection occurring between 0.5-1 hr following ECM adhesion ( Fig.2 ). Nonlinear regression analyses of normalized data with variable slope revealed a significant delay in pERK activation in HMEC from older women following binding to COL1 or LAM ( Fig.2A ). Cells bound to FN showed no differences in pERK activation kinetics ( Fig.2B ). In contrast, pAKT induction in adhered HMEC remained relatively stable at the measured timepoints (Suppl. Fig.3A )
Given that MEP reside in the basal compartment, we monitored pERK and pAKT levels in the MEP subpopulation between 0-9 hr post-ECM adhesion (Suppl. Interestingly, MEP from the older women appeared to reach maximal pAKT levels on COL1 and FN earlier than the young (Suppl. Fig.3Bii ). Overall, HMEC from older women displayed altered ECM responsiveness.
Integrin activation by ECM decreases with age
Next, we asked if HMEC cell adhesion to different ECM was affected by age.
Interestingly, overall cell adhesion increased with age, both in percentage of adhered cells within a given time and as the rate of adhesion (Suppl. Fig.4Aii and B). This is consistent with previous results showing that HMEC aging is associated with increased basal characteristics 16 . Congruently, total surface integrin levels on HMEC increased with age (Suppl. Fig.5 ). We further determined whether there were changes in the relative proportion of activated integrins (ITG) in HMEC adhered to ECM-coated microspheres by measuring ITGβ1 and ITGβ4 phosphorylation and downstream pSrc levels (Fig.3 ). The ratio of integrin activation in LEP to MEP was used to determine the extent of basal identity as a function of age, where values >0 were defined as more basallike, and <0 more luminal-like in a COL1 context. This analysis indicated that LEP acquired a significantly greater basal identity with increasing age (Fig.3Bii ).
This was significant for Src activation in a context of COL1 as a function of age, with a similar trend found for all integrins measured. This relative increase in integrin activation levels was mainly due to reduced integrin phosphorylation in the MEP subpopulation. However, taking into account the increase in overall integrin expression (Suppl. Fig.5B ), we found that relative integrin activation decreased with age in both LEP and MEP ( Fig.3C) , with a significant decrease for ITGβ4 phosphorylated on Y1510. Taken together our findings suggested that LEP acquire a basal identity with age, while relative integrin activation in a context of COL1 decreased in both LEP and MEP with age.
Age-related susceptibility of HMEC to oncogene induced senescence
We questioned whether the observed age-related changes in HMEC responsiveness to ECM could affect tumor suppressive mechanisms and alter susceptibility to oncogenic transformation. Oncogene induced senescence (OIS) is a key protective mechanism triggered by abnormal cell signaling 17 . We investigated by the use of a constitutive active EGFR mutant oncogene (EGFR Del19 ), whether there were age-related differences in OIS induction in prestasis HMEC. EGFR Del19 or empty retroviral vectors was introduced into prestasis HMEC. EGFR Del19 expressing cells were sorted 48 hours later to ensure uniform EGFR expression (Suppl. Fig.6A ), and EGFR expression was followed during cell passaging (Suppl. Fig.6B ). Cells with empty retroviral vector were selected by antibiotics. EGFR Del19 oncogene dependency in transduced cells was confirmed by erlotinib sensitivity (Suppl. Fig.7 ). Cells were allowed to adhere to ECM-coated microspheres, followed by cell signal analysis by microsphere cytometry (Fig.4A ). Serum-deprivation was applied to secure mutant EGFR signaling (open dots); some sample pairs had additional EGF treatment (closed dots). Isogenic immortalized and tumorigenic cell lines were included for comparison. Data was plotted as the log2 value of signaling in EGFR Del19 -overexpressing cells versus empty retroviral vector-transduced cells as a function of age. Linear regression analysis revealed a reduction of EGFR Del19 -induced pERK and pAKT with HMEC age. We quantified senescence by measuring β-galactosidase activity with X-Gal (blue) in EGFR Del19 -expressing HMEC from a 28 and 58y woman (Fig.4B ). The HMEC from younger women showed large vacuoles and reduced proliferation rapidly after expression of EGFR Del19 . In contrast, the HMEC from the older women displayed less βgalactosidase activity, and demonstrated a mesenchymal morphology. These cells proliferated for several passages beyond the younger EGFR Del19transduced HMEC (Fig.4C ). Collectively, these results suggest that triggering of OIS by oncogenic EGFR expression was reduced in HMEC with age, consistent with an increased susceptibility to oncogenic transformation.
Discussion
Aging is associated with both intrinsic and extrinsic changes in the mammary epithelium. The post-menopausal breast microenvironment is characterized by basal membrane degradation, an increasingly collagenous stroma and gradual replacement of a senescent epithelia with soft adipose and inflammatory cells 18 . Aging HMEC, originally sequestered by a basal membrane consisting of LAM and COL4, become exposed to different ECM components such as FN and COL1, normally only encountered during development, wound healing and inflammation 19, 20 .
We show that PI3K and MAPK signaling following HMEC cell adhesion to LAM and FN is attenuated with age ( Fig.1, Fig.2 ). This reduced responsiveness correlates with changes in integrin expression and function (Suppl. Fig.5, Fig.3 ).
Our single cell-level microsphere cytometry analysis revealed that this was due to reduced signal magnitude and not a reduction in the number of responding cells (Suppl. Fig.2C ). HMEC from younger women demonstrated distinctive pERK responses to COL1, FN or LAM, while responses in HMEC from older women were largely independent of ECM type (Suppl. Fig.1 ). We also detected lower levels of ITGβ4 activation in LEP from older women (Fig.3C) , indicating a change in ECM-mediated cell signaling with age.
LEP normally have lower integrin expression than MEP which reside in the basal compartment. ITGα2 and ITGβ1 were the most prevalent on both LEP and MEP (Suppl. Fig.5B ). However, we observed increased expression of ITGα2, ITGβ1, ITGα6 and ITGβ4 integrins on LEP with increasing age. This is consistent with earlier observations that LEP acquire basal traits with age 16 . It may be related to a concomitant reduction in the total number of MEP and structural alternations in the basal membrane with age that disrupt the epithelial bilayer and give LEP abnormal access to the ECM 21 . This breakdown in normal tissue architecture is thus associated with age-emergent cellular phenotypes with altered cell signaling responses. Oncogenic mutations in healthy cells that enhance cell signaling normally induce senescence (OIS) 22 . We show that the attenuated cell signaling responses in HMEC derived from older women can subvert this important tumor defense mechanism. ERK and AKT activation levels generated by an oncogenic form of EGFR were reduced in older HMEC (Fig.4 ). This surprising result indicates that HMEC, with age-induced epigenetic alterations, may be less prone to OIS and thus more likely to tolerate oncogenic mutations.
This raises the interesting possibility that drugs targeting epigenetic regulators could be used in breast cancer prevention [23] [24] [25] .
Materials and Methods
Coating of Microspheres with Extracellular Matrix Proteins
VARIAN PL-Microspheres SuperCarbonyl White poly(styrene-co-methancrylic acid) 20 μm in diameter (Batch CD185, Agilent Technologies) were coated as described 13 . E-Cadherin (1 µg mL -1 , Sino-Biological Inc. #10204-H08H) was added to the coating suspension..
Cell culture
Finite life span mammary epithelial cells were obtained from women having undergone reduction mammoplasty, and generously provided from the HMEC biobank 26 . Cells were cultured in M87A complete medium as described 13 
Microsphere cytometry protocol
Cultured cells were washed twice with PBS and treated with low concentration trypsin (0.05% trypsin, 0.02% EDTA in PBS). Microsphere adhesion was performed as described 13 . Cell -microsphere incubation time varied between 2-6 hours depending on cell type and choice of ECM coating. Microspherebound cells were serum starved for 35 min. prior to stimulation with M87A complete medium for 20 min. (Fig.1) or EGF 20 ng mL -1 for 10 min. (Fig.4A ).
However, EGFR-transduced microsphere-bound cells were mainly cultured in serum-free medium throughout the experiment (Fig.4A ). Kinetic analysis of microsphere-bound cell activation, and measurement of integrin expression and activated integrin levels were performed in M87 complete medium ( Fig.2 and   Fig.3 ). Pre-treatment (2hr) with MAPK inhibitor PD98059 (20 μM, Cell Signaling #9900) and PI3K inhibitor wortmannin (0.5 μM, Sigma-Aldrich #W1628) was used to set a gate defining the positive population of cells with active ERK or active AKT respectively ( Fig.1 and 4) . Cell-microsphere complexes were fixed and permeabilized as described 13 .
Flow cytometry analysis
Fixed, permeabilized cell-microsphere complexes were stained as described 28 .
We used the following rabbit primary antibodies diluted in 1% bovine serum albumin in PBS as a blocking buffer: anti-pERK, ( Staining of microsphere bound cells was performed in two steps: 1) staining of intracellular epitopes with primary antibodies against phosphorylated proteins (pERK, pAKT, pITGβ1, pSrc, pITGβ4); 2) Staining of cell surface markers (CD227, CD10, CD117) combined with secondary antibodies against the rabbit primary antibodies used in the first step, in addition to a DNA stain.
Kinetic signal transduction analysis
The kinetic experiments were initiated in M87 complete medium. Microspherebound cells were treated according to protocol described above. Cellmicrosphere complexes were collected at 10, 30, 45, 60, 120, 240 and 540 min.
by adding PFA and methanol as described above. Median fluorescence intensity was plotted according to increasing period of ECM/microsphere exposure.
Kinetic signaling data was normalized by calculating log2 of the ratio of sample fluorescence against background fluorescence. Background was defined as the fluorescence of a control sample stained with secondary antibody only. In order to investigate significant differences in kinetics, we recalculated the sample values into ratio values where minimum value of the experiment data was set to 0 and maximum value was set to 100. From this set-up EC50 values were obtained and significant differences in kinetics could be detected. Adhesion kinetics was plotted as Hill's curve, and area under the curve was calculated to investigate significant differences in cell-microsphere adhesion. Experiments were performed in three parallels. Samples were run on BD LSRFortessa (BD Biosciences).
Extraction of cells from organoids
Cryostored organoids were thawed in a 37 o C water bath and transferred to a 50 mL Falcon tube, followed by centrifugation at 450g for 5 min. in a volume of 30 mL PBS. Supernatant was aspirated and the pellet gently resuspended in 3 mL 0.25% Trypsin/EDTA. The suspension was placed on an orbital shaker for 10 min. at room temperature, followed by vigorous shaking for 30 seconds. 10 mL of medium was added to neutralize trypsin and the suspension was filtered through multiple 70 µm strainers until no visible debris was found in the filtrate.
Filtrate was pelleted by 600g centrifugation for 5 min. and stained directly for integrin analysis.
Erlotinib-treatment
The following concentrations of Erlotinib were tested: 0, 1, 3, 10, 30, 100, 300, Experiment was performed as described in CellTiter-Blue®Cell Viability Assay protocol from Promega.
Senescence associated β-Galactosidase activity
β-galactosidase assay was performed as described 29 , with a buffer pH at 6 to selectively stain only senescent cells growing in cell culture dishes. Cells were washed 3X with PBS before adding fixative. Microsphere-bound cells were stained overnight, washed and images were retrieved in a phase-contrast microscope.
Statistics
All statistical tests were performed in GraphPad Prism 6 Fig.1 . Mammary epithelial cell signaling responses to ECM is attenuated with age. Relative activation presented as the log2 ratio of phosphorylated integrin over total integrin.
Figures
(significance difference = solid line, not significant = dotted line). Suppl. Fig.1 . Mammary epithelial cell pERK responsiveness to fibronectin is reduced with age. pERK levels in HMEC from women < 30y and > 62y adhered to COL1, FN or LAM were measured. HMEC from 10 women between the age of 19 and 91 were included. The pERK GMFI (geometric mean fluorescence intensity) values compared were defined according to description in Fig.1 (C) . HMEC from younger women showed a stronger pERK responsiveness when bound to FN than to COL1 or LAM. *P<0.5 
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